by HBOT News | Oct 11, 2016 | Diabetic Foot Ulcers
Abstract: Diabetic foot ulcers (DFUs) are one of the most common indications for hyperbaric oxygen treatment (HBOT). The role of HBOT in DFUs is often debated. Recent evidence based guidelines, while recommending its use, urge further studies to identify the patient...
by HBOT News | Mar 16, 2016 | Diabetic Foot Ulcers
Abstract: Delayed closure of foot ulcers is a primary factor leading to lower extremity amputation in patients with diabetes, creating great demand for products or therapies to accelerate the rate of wound closure in this population. This study (ClinicalTrials.gov...
by HBOT News | Nov 23, 2015 | Necrotizing Fasciitis
Abstract: New biomarkers are needed to assess the severity of necrotizing soft tissue infection (NSTI) at an early stage and to individualize treatment strategies. We assessed pentraxin-3 (PTX3) as a marker of disease severity and risk of death in patients with NSTI....
by HBOT News | Nov 10, 2015 | Necrotizing Fasciitis
Abstract: Hyperbaric oxygen treatment (HBOT) is used to treat acute and chronic wounds. This systematic review was conducted to summarise and evaluate existing evidence on the costs associated with HBOT in the treatment of wounds. We searched multiple electronic...
by HBOT News | Nov 10, 2015 | Diabetic Foot Ulcers
Abstract: Hyperbaric oxygen treatment (HBOT) is used to treat acute and chronic wounds. This systematic review was conducted to summarise and evaluate existing evidence on the costs associated with HBOT in the treatment of wounds. We searched multiple electronic...
